Now it’s getting to be something of a pattern.
Another PhD with extensive drug company experience bales from his position with an operating pharmaceutical and elects to sign on with a small biotech startup that has no manufacturing facilities, no sales force, and no revenues because the company has no approved drugs.
Like all of the other new, recent drug-expert employees hitching their careers to the Anavex train — which is still at idle in the station — what could this Dr. Jeffrey Edwards, Vice President of Clinical Pharmacology and Science at Anavex Life Sciences, know or believe about his new employer? Might he have some information none of us have learned yet?
Market Data 
Markets 
AI
